1Y Close · As of Aug 26, 2026
BUKWANG PHARMACEUTICAL IND operates in the Pharmaceuticals sector.
Legal name: BUKWANG PHARMACEUTICAL IND CO.,LTD
In fiscal year 2025, BUKWANG PHARMACEUTICAL IND (003000) reported revenue of 200.7 billion KRW, up 25.4% from 160.1 billion KRW a year earlier.
Operating profit was 14.2 billion KRW and net income was 12.4 billion KRW in the same year.
As of the Aug 26, 2026 close, the market capitalization was 415.4 billion KRW, with a P/B of 1.22.
These figures can be verified in the DART filing (receipt no. 20260316001273).
Financials
| Year | Rev | Op Inc | Net Inc |
|---|---|---|---|
| 2025 | 200.7B | 14.2B | 12.4B |
| 2024 | 160.1B | 1.6B | -3.5B |
| 2023 | 125.9B | -37.5B | -34.4B |
Checks
1 of 8 checked items currently applicable.
Market Cap & Price: Market cap is above the delisting threshold.
Administrative Designation: No administrative designation criteria met.
Audit Opinion: Audit opinion: Unqualified (clean).
Convertible Bonds: No convertible bonds outstanding.
Capital Increase: No capital-increase filings in the last 180 days.
Treasury Stock: No treasury stock filings.
Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.
Major Shareholder Change: No major shareholder changes in the last 180 days.
Recent Filings
| Date | Filing |
|---|---|
| 2026-08-26 | 유형자산취득결정 |
| 2026-08-14 | 출자법인회생절차및파산관련신청 |
| 2026-08-13 | Payment and Dispute Resolution |
| 2026-08-13 | Semi-Annual Report (2026.06) |